Robotic technology in interventional cardiology: Current status and future perspectives
Robotic technology in interventional cardiology: Current status and future perspectives
复制标题
DOI：
10.1002/ccd.27209
复制
发表时间：
2017-11-15
影响因子：
2.3
通讯作者：
Reeves, Ryan R.
中科院分区：
文献类型：
--
作者：
Mahmud, Ehtisham;Pourdjabbar, Ali;Reeves, Ryan R.
机器人技术在心血管医学中的应用已有十多年了，在此期间，其用途已扩展到经皮冠状动脉和外周血管介入治疗。机器人辅助经皮心血管介入治疗的安全性和可行性已在包括简单到复杂的冠状动脉病变以及髂骨和股腘动脉病变的研究中得到证明。这些报告表明，机器人辅助 PCI 显着减少了操作员接触有害电离辐射的机会，且不会对手术成功或临床疗效产生不利影响。此外，机器人技术的使用具有直观的好处，可以减轻介入操作者面临的骨科损伤风险。除了介入操作员的好处之外，机器人辅助介入还可以通过允许更准确的病变长度测量、精确的支架放置和更低的患者辐射暴露来为患者带来好处。然而，需要进一步调查才能充分阐明这些潜在的好处。
Robotic technology has been utilized in cardiovascular medicine for over a decade, and over that period, its use has been expanded to percutaneous coronary and peripheral vascular interventions. The safety and feasibility of robotically assisted percutaneous cardiovascular interventions has been demonstrated in studies including simple to complex coronary lesions, and both iliac and femoropopliteal lesions. These reports have shown that robotically assisted PCI significantly reduces operator exposure to harmful ionizing radiation without a detrimental effect on procedural success or clinical efficacy. Additionally, the use of robotics has the intuitive benefit of alleviating the risk of orthopedic injuries faced by interventional operators. In addition to the interventional operator benefits, robotically assisted intervention has the potential for patient level benefit by allowing more accurate lesion length measurement, precise stent placement, and lower patient radiation exposure. However, further investigation is required to fully elucidate these potential benefits.